Skip to content

US HIV physicians routinely offering early ART but only a third have prescribed PrEP

Recent infection and ART treatment interruptions are key periods for HIV transmission

New HCV NS5A inhibitor EDP-239 looks good in early studies, more evidence supports early hepatitis C treatment

PrEP preferences in gay men are predicted by the frequency and predictability of the sex they have

WHO guidelines recommend universal antiretroviral treatment, PrEP for those at substantial risk

Gottfried Hirnschall, director of WHO's Department of HIV/AIDS. Photo by Liz Highleyman, hivandhepatitis.com

The enduring power of stigma – understanding why HIV-positive gay men don’t disclose their status

High standards of care associated with reduced mortality risk of patients with HIV

Second UK cost-effectiveness study finds that large PrEP programmes may need drug price cut to be affordable

Substantial improvement in life expectancy of older HIV-positive patients in modern treatment era, report Danes